Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Kenneth Allen Myszkowski. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Kenneth Allen Myszkowski har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:ARWR / Arrowhead Pharmaceuticals, Inc. Chief Financial Officer 455 433
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Kenneth Allen Myszkowski. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Kenneth Allen Myszkowski som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2025-01-07 2025-01-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale −10 000 455 433 −2,15 19,69 −196 900 8 967 476
2025-01-07 2025-01-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −8 000 465 433 −1,69 19,70 −157 600 9 169 030
2025-01-07 2025-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −9 402 473 433 −1,95 20,10 −188 980 9 516 003
2025-01-07 2025-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −17 765 482 835 −3,55 19,68 −349 615 9 502 193
2025-01-07 2025-01-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 100 000 500 600 24,96
2024-03-08 2024-03-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale −40 000 400 600 −9,08 35,19 −1 407 600 14 097 114
2024-01-08 2024-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −8 904 440 600 −1,98 35,65 −317 428 15 707 390
2024-01-08 2024-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −5 800 449 504 −1,27 34,97 −202 826 15 719 155
2024-01-08 2024-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 400 455 304 −0,31 34,04 −47 656 15 498 548
2024-01-08 2024-01-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 75 000 456 704 19,65
2023-06-29 2023-06-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale −15 000 381 704 −3,78 36,20 −543 000 13 817 685
2023-01-05 2023-01-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 60 000 396 704 17,82
2022-12-30 2022-12-29 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −30 625 336 704 −8,34 40,00 −1 225 000 13 468 160
2022-09-30 2022-06-15 5 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift −96 676 367 329 −20,84
2022-01-06 2022-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −3 786 464 005 −0,81 63,95 −242 115 29 673 120
2022-01-06 2022-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −3 778 467 791 −0,80 63,17 −238 656 29 550 357
2022-01-06 2022-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −16 528 471 569 −3,39 62,00 −1 024 736 29 237 278
2022-01-06 2022-01-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −15 908 488 097 −3,16 60,50 −962 434 29 529 868
2022-01-04 2022-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 60 000 504 005 13,51
2021-01-12 2021-01-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale −1 441 444 005 −0,32 81,00 −116 721 35 964 405
2021-01-12 2021-01-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale −11 597 445 446 −2,54 81,02 −939 589 36 090 035
2021-01-07 2021-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −25 166 457 043 −5,22 72,63 −1 827 807 33 195 033
2021-01-07 2021-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −4 359 482 209 −0,90 71,77 −312 845 34 608 140
2021-01-07 2021-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 100 486 568 −0,23 70,75 −77 825 34 424 686
2021-01-05 2021-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 60 000 487 668 14,03
2020-11-12 2020-11-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −43 505 0 −100,00
2020-11-12 2020-11-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale −17 665 427 668 −3,97 69,86 −1 234 077 29 876 886
2020-11-12 2020-11-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale −25 840 445 333 −5,48 69,04 −1 783 994 30 745 790
2020-11-12 2020-11-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 43 505 471 173 10,17 14,54 632 563 6 850 855
2020-10-22 2020-10-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −29 166 43 505 −40,13
2020-10-22 2020-10-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale −29 166 427 668 −6,38 54,04 −1 576 131 23 111 179
2020-10-22 2020-10-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 29 166 456 834 6,82 6,15 179 371 2 809 529
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −10 834 72 671 −12,97
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −12 116 83 505 −12,67
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −6 495 95 621 −6,36
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −2 000 102 116 −1,92
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −12 000 104 116 −10,33
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10 834 427 668 2,60 6,15 66 629 2 630 158
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 12 116 416 834 2,99 7,75 93 899 3 230 464
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6 495 404 718 1,63 14,54 94 437 5 884 600
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2 000 398 223 0,50 5,19 10 380 2 066 777
2020-02-27 2020-02-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 12 000 396 223 3,12 9,90 118 800 3 922 608
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −33 351 116 116 −22,31
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −3 450 384 223 −0,89 52,13 −179 848 20 029 545
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −10 680 387 673 −2,68 51,11 −545 855 19 813 967
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −2 800 398 353 −0,70 49,98 −139 944 19 909 683
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −10 554 401 153 −2,56 49,07 −517 885 19 684 578
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −6 432 411 707 −1,54 47,93 −308 286 19 733 117
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −6 397 418 139 −1,51 47,07 −301 107 19 681 803
2020-01-23 2020-01-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 33 351 424 536 8,53 5,19 173 092 2 203 342
2020-01-08 2020-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −500 391 185 −0,13 60,95 −30 475 23 842 726
2020-01-08 2020-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −11 907 391 685 −2,95 60,40 −719 183 23 657 774
2020-01-08 2020-01-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −7 593 403 592 −1,85 59,60 −452 543 24 054 083
2020-01-03 2020-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 85 000 411 185 26,06
2019-11-07 2019-11-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −12 649 149 467 −7,80
2019-11-07 2019-11-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 12 649 326 185 4,03 5,19 65 648 1 692 900
2019-11-01 2019-11-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −37 884 162 116 −18,94
2019-11-01 2019-11-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −16 620 313 536 −5,03 41,21 −684 910 12 920 819
2019-11-01 2019-11-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −21 264 330 156 −6,05 40,56 −862 468 13 391 127
2019-11-01 2019-11-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 37 884 351 420 12,08 7,75 293 601 2 723 505
2019-06-03 2019-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −20 000 200 000 −9,09
2019-06-03 2019-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −15 000 220 000 −6,38
2019-06-03 2019-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 20 000 313 536 6,81 5,19 103 800 1 627 252
2019-06-03 2019-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 15 000 293 536 5,39 4,60 69 000 1 350 266
2019-05-22 2019-05-21 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −27 071 278 536 −8,86 22,00 −595 562 6 127 792
2019-02-20 2019-02-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −8 000 235 000 −3,29
2019-02-20 2019-02-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −8 000 305 607 −2,55 18,00 −144 000 5 500 926
2019-02-20 2019-02-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8 000 313 607 2,62 5,20 41 600 1 630 756
2019-01-18 2019-01-17 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −81 875 305 607 −21,13 14,55 −1 191 281 4 446 582
2019-01-03 2019-01-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale −8 333 387 482 −2,11 11,98 −99 829 4 642 034
2019-01-03 2019-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 85 000 395 815 27,35
2018-09-10 2018-09-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −20 000 243 000 −7,60
2018-09-10 2018-09-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −25 000 263 000 −8,68
2018-09-10 2018-09-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −20 000 310 815 −6,05 21,01 −420 200 6 530 223
2018-09-10 2018-09-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −25 000 330 815 −7,03 18,00 −450 000 5 954 670
2018-09-10 2018-09-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 20 000 355 815 5,96 4,75 95 000 1 690 121
2018-09-10 2018-09-06 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 25 000 335 815 8,04 2,62 65 500 879 835
2018-06-20 2018-06-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −20 000 288 000 −6,49
2018-06-20 2018-06-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −20 000 310 815 −6,05 14,01 −280 200 4 354 518
2018-06-20 2018-06-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 20 000 330 815 6,43 2,01 40 200 664 938
2018-06-01 2018-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −12 600 308 000 −3,93
2018-06-01 2018-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −12 600 310 815 −3,90 11,00 −138 600 3 418 965
2018-06-01 2018-05-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 12 600 323 415 4,05 2,01 25 326 650 064
2018-06-01 2018-05-30 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −1 400 320 600 −0,43
2018-06-01 2018-05-30 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 400 310 815 −0,45 11,00 −15 400 3 418 965
2018-06-01 2018-05-30 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1 400 312 215 0,45 2,01 2 814 627 552
2018-03-27 2018-03-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −20 000 322 000 −5,85
2018-03-27 2018-03-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −20 000 310 815 −6,05 8,00 −160 000 2 486 520
2018-03-27 2018-03-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 20 000 330 815 6,43 2,01 40 200 664 938
2018-03-05 2018-03-05 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
F - Taxes −8 208 310 815 −2,57 6,66 −54 665 2 070 028
2018-01-03 2018-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 75 000 319 023 30,73
2017-10-06 2017-06-08 5 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift −16 666 244 023 −6,39
2017-01-04 2017-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 145 000 260 689 125,34
2016-08-26 2016-08-23 4/A ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −6 900 342 000 −1,98
2016-08-26 2016-08-23 4/A ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −6 900 115 689 −5,63 8,00 −55 200 925 512
2016-08-26 2016-08-23 4/A ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6 900 122 589 5,96 2,01 13 869 246 404
2016-08-26 2016-08-22 4/A ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −13 100 348 900 −3,62
2016-08-26 2016-08-22 4/A ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X −13 100 115 689 −10,17 8,00 −104 800 925 512
2016-08-26 2016-08-22 4/A ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 13 100 128 789 11,32 2,01 26 331 258 866
2016-08-24 2016-08-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −6 900 342 000 −1,98
2016-08-24 2016-08-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale −6 900 115 689 −5,63 8,00 −55 200 925 512
2016-08-24 2016-08-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6 900 122 589 5,96 2,01 13 869 246 404
2016-08-24 2016-08-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise −13 100 348 900 −3,62
2016-08-24 2016-08-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale −13 100 115 689 −10,17 8,00 −104 800 925 512
2016-08-24 2016-08-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 13 100 128 789 11,32 2,01 26 331 258 866
2016-03-08 2016-03-04 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
F - Taxes −6 263 115 689 −5,14 4,33 −27 119 500 933
2016-02-09 2016-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
F - Taxes −13 048 121 952 −9,67 3,46 −45 146 421 954
2016-01-04 2016-01-01 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 40 000 362 000 12,42
2016-01-04 2016-01-01 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
A - Award 50 000 135 000 58,82
2016-01-04 2015-12-30 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
S - Sale −23 347 85 000 −21,55 6,13 −143 117 521 050
2016-01-04 2015-12-30 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
F - Taxes −13 153 108 347 −10,83 6,13 −80 628 664 167
2015-03-06 2015-03-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 50 000 322 000 18,38
2015-03-06 2015-03-04 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
A - Award 50 000 121 500 69,93
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option (right to buy)
M - Exercise −25 000 272 000 −8,42
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option (right to buy)
M - Exercise −15 000 297 000 −4,81
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
S - Sale −40 000 71 500 −35,87 14,02 −560 860 1 002 537
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
M - Exercise 25 000 111 500 28,90 7,00 175 000 780 500
2014-08-19 2014-08-15 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
M - Exercise 15 000 86 500 20,98 5,19 77 850 448 935
2014-02-12 2014-02-12 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
M - Exercise −16 000 312 000 −4,88
2014-02-12 2014-02-12 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
S - Sale −16 000 71 500 −18,29 18,77 −300 290 1 341 919
2014-02-12 2014-02-12 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
M - Exercise 16 000 87 500 22,38 2,01 32 160 175 875
2014-02-10 2014-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Options
A - Award 50 000 328 000 17,99
2014-02-10 2014-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
A - Award 70 000 71 500 4 666,67
2013-09-24 2013-09-21 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 20 000 278 000 7,75
2013-05-08 2013-05-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 90 000 258 000 53,57
2012-10-02 2012-09-28 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 25 000 168 000 17,48
2012-02-21 2012-02-16 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 83 000 143 000 138,33
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)